{"id":"W2271971696","doi":"10.21037/jgo.2016.01.03","title":"Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial","year":2016,"lang":"en","type":"article","venue":"Journal of Gastrointestinal Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Celgene","keywords":"Medicine; Gemcitabine; Neutropenia; Pancreatic cancer; Adverse effect; Internal medicine; Paclitaxel; Deoxycytidine; Population; Chemotherapy; Cancer; Nab-paclitaxel; Oncology; Febrile neutropenia; Gastroenterology; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001259876,0.000270759,0.001786539,0.0003815152,0.00008074918,0.000009959849,0.0001682829,0.00007833019,0.0001283764],"category_scores_gemma":[0.003364451,0.0001509416,0.0001925188,0.0002086662,0.0005305748,0.0001893442,0.00003872445,0.0002972935,0.000002383319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006461388,"about_ca_system_score_gemma":0.001891319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005932788,"about_ca_topic_score_gemma":0.00001682443,"domain_scores_codex":[0.9971557,0.0002443968,0.001315213,0.0002742891,0.0005166077,0.0004937474],"domain_scores_gemma":[0.9935542,0.002774722,0.001508375,0.0002469379,0.001467255,0.0004485383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8090577,0.006306515,0.1400594,0.0003630774,0.0009526809,0.0001938431,0.0003120933,0.00001352163,0.01029319,0.0001820225,0.001258188,0.03100775],"study_design_scores_gemma":[0.6430906,0.1725797,0.1756271,0.001567362,0.003040095,0.002046995,0.0001753035,0.0006805895,0.000170985,0.0002147498,0.0006063466,0.0002002037],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814144,0.0002139562,0.01305488,0.003193429,0.0001122172,0.001826162,0.00006771129,0.00001099161,0.0001062247],"genre_scores_gemma":[0.9620904,0.0001809075,0.03688518,0.00009252249,0.0003246746,0.00008440746,0.0000142343,0.00003324912,0.0002943746],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1662732,"threshold_uncertainty_score":0.6155222,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05354838783683344,"score_gpt":0.398360638520579,"score_spread":0.3448122506837455,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}